Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Guida

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|January 1, 2019
Annalisa Guida, Laurence Albiges
Expert Review of Anticancer Therapy|September 6, 2018
Treating patients with renal cell carcinoma and bone metastasesAnnalisa Guida, Bernard Escudier, Laurence Albiges
Urologic Oncology|January 24, 2026
Circulating tumor DNA in urothelial cancer as an intermediate disease state between localized and advanced stages: Moving from risk factors to micrometastatic disease in the perioperative settingSergio Bracarda, Giulia Mammone, Claudia Mosillo, et al.
Cancer Treatment Reviews|February 19, 2021
Finding predictive factors for immunotherapy in metastatic renal-cell carcinoma: What are we looking for?Annalisa Guida, Roberto Sabbatini, Lara Gibellini, et al.
Cancer Treatment Reviews|May 19, 2024
The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancerAnnalisa Guida, Claudia Mosillo, Giulia Mammone, et al.
Clinical Genitourinary Cancer|September 11, 2017
Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave RoussyAnnalisa Guida, Laurence Albiges, Lisa Derosa, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2020
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic reviewRaffaele Ratta, Annalisa Guida, Florian Scotté, et al.
Cancers|September 9, 2022
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?Claudia Mosillo, Maria Letizia Calandrella, Claudia Caserta, et al.
Oncotarget|December 21, 2020
Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinomaAnnalisa Guida, Gwénaël Le Teuff, Carolina Alves, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2021
Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell CarcinomaRitesh R Kotecha, Ronan Flippot, Taylor Nortman, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|January 1, 2019
Annalisa Guida, Laurence Albiges
Expert Review of Anticancer Therapy|September 6, 2018
Treating patients with renal cell carcinoma and bone metastasesAnnalisa Guida, Bernard Escudier, Laurence Albiges
Urologic Oncology|January 24, 2026
Circulating tumor DNA in urothelial cancer as an intermediate disease state between localized and advanced stages: Moving from risk factors to micrometastatic disease in the perioperative settingSergio Bracarda, Giulia Mammone, Claudia Mosillo, et al.
Cancer Treatment Reviews|February 19, 2021
Finding predictive factors for immunotherapy in metastatic renal-cell carcinoma: What are we looking for?Annalisa Guida, Roberto Sabbatini, Lara Gibellini, et al.
Cancer Treatment Reviews|May 19, 2024
The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancerAnnalisa Guida, Claudia Mosillo, Giulia Mammone, et al.
Clinical Genitourinary Cancer|September 11, 2017
Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave RoussyAnnalisa Guida, Laurence Albiges, Lisa Derosa, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2020
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic reviewRaffaele Ratta, Annalisa Guida, Florian Scotté, et al.
Cancers|September 9, 2022
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?Claudia Mosillo, Maria Letizia Calandrella, Claudia Caserta, et al.
Oncotarget|December 21, 2020
Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinomaAnnalisa Guida, Gwénaël Le Teuff, Carolina Alves, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2021
Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell CarcinomaRitesh R Kotecha, Ronan Flippot, Taylor Nortman, et al.
Pageof 5